Rare diseases
Investigational molecules
Locations
Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
GermanyDose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis
GermanyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
GermanyA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
GermanyA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
GermanyEfficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
GermanyEfficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
GermanyA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
GermanyA study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
